CCL1 Gene Therapy to Inhibit Bacterial Translocation in Acute Radiation Syndrome

StatusFinished
Effective start/end date15/05/1330/04/18

Funding

  • UniversityTexasMed Branch Galveston: $229,728.00

Keywords

  • Immunology, Radiation Associated Illness